ReviewJournal of pain research2026
The Translational Biology of Temporomandibular Disorder Pain: Mechanisms, Biomarkers, and Therapeutic Perspectives.
Review in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Temporomandibular disorders (TMDs) are among the most common causes of chronic orofacial pain, yet their underlying biology remains incompletely integrated across disciplines. This review synthesizes current translational evidence linking peripheral nociceptive mechanisms in the temporomandibular joint and masticatory muscles with trigeminal neuroimmune signaling, central sensitization, biomarker development, and targeted therapeutic strategies. We highlight the roles of mechanotransduction, inflammatory and neuropeptide signaling, endocrine-autonomic influences, psychosocial factors, and preclinical models in shaping disease heterogeneity and chronicity. By organizing the literature within a translational framework, this review positions TMD as a biologically heterogeneous, multisystem pain condition rather than a purely local joint or muscle disorder. This perspective highlights candidate mechanisms and biomarkers as promising research tools, while recognizing that current clinical management remains grounded in biopsychosocial assessment, clinical phenotyping, education, self-management, and non-surgical care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.